首页> 外国专利> Compound compositions to treat a cardiovascular disease marked by hypertension or hypertension or myocardial ischemia improve ischemic damage or reduce the size of myocardial infarction and reduce levels of triglyceride lipids or cholesterol in a mammal and processes to treat a patient suffering from hypertension myocardial ischemia and hyperlipidemia or hypercholesterolin to improve ischemic damage or the size of myocardial infarction in a patient and to prepare a substantially optically pure derivative of 2-substituted-2-starch-1- (heteroar-2-3-il) ethane

Compound compositions to treat a cardiovascular disease marked by hypertension or hypertension or myocardial ischemia improve ischemic damage or reduce the size of myocardial infarction and reduce levels of triglyceride lipids or cholesterol in a mammal and processes to treat a patient suffering from hypertension myocardial ischemia and hyperlipidemia or hypercholesterolin to improve ischemic damage or the size of myocardial infarction in a patient and to prepare a substantially optically pure derivative of 2-substituted-2-starch-1- (heteroar-2-3-il) ethane

机译:用于治疗以高血压或高血压或心肌缺血为特征的心血管疾病的化合物组合物可改善哺乳动物的缺血性损伤或减小心肌梗塞的大小并降低甘油三酯脂质或胆固醇的水平,以及治疗患有高血压,心肌缺血和高脂血症或高胆固醇素,可改善患者的缺血性损伤或心肌梗塞的大小,并制备基本呈光学纯的2-取代-2-淀粉-1-(杂2-3-3il)乙烷衍生物

摘要

This invention relates to the use of derivatives and analogs of formula (I) which possess adenosine agonist activity and are useful as anti-hypertensive and anti-ischemic agents, to pharmaceutical compositions including such compounds, and to their use in treating hypertension and myocardial ischemia, and to methods and intermediates used in the preparation of such compounds, CHEM wherein; K is CH; Q is CH2 or O: T is CHEM or R3O-CH2; X is straight or branched chain alkylene, cycloalkylene or cycloalkenylene group, each of which is optionally substituted by at least one CH3, CH3CH2, Cl, F, CF3 or CH3O; Y is NR4, O or S; a = 0 or 1; Z is of the formula CHEM Z1 is N, CR5, (CH)m-CR5 or (CH)m-N, m being 1 or 2; Z2 is N, NR6, O or S, n being 0 or 1; R1, R2, R3, R4, R5 and R6 are indepenfently H, alkyl, aryl or heterocyclyl; Ra, Rb, R', R'' as defined in the application.s
机译:本发明涉及具有腺苷激动剂活性并可用作抗高血压和抗缺血剂的式(I)的衍生物和类似物的用途,涉及包含此类化合物的药物组合物,及其在治疗高血压和心肌缺血中的用途。以及用于制备此类化合物的方法和中间体, K是CH; Q为CH2或O:T为或R3O-CH2; X是直链或支链的亚烷基,亚环烷基或亚环烯基,它们各自任选地被至少一个CH 3,CH 3 CH 2,Cl,F,CF 3或CH 3 O取代; Y为NR 4,O或S; a = 0或1; Z为式。Z1为N,CR5,(CH)m-CR5或(CH)m-N,m为1或2; Z 2为N,NR 6,O或S,n为0或1; R1,R2,R3,R4,R5和R6独立地为H,烷基,芳基或杂环基;在应用程序中定义的Ra,Rb,R',R''

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号